查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床檢驗服務的全球市場:策略和趨勢，預測 - 各化驗類型，場所，各產品，各國:情形分析，附執行顧問指南(2025年～2029年)
市場調查報告書
商品編碼
1597906

臨床檢驗服務的全球市場:策略和趨勢，預測 - 各化驗類型，場所，各產品，各國:情形分析，附執行顧問指南(2025年～2029年)

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 367 Pages | 商品交期: 最快1-2個工作天內

價格

雖然臨床測試面臨新冠病毒的挑戰，但大流行的結束催生了新的診斷方法。雖然現場護理和自我檢測威脅臨床檢測服務的長期需求，但分子診斷正在推動快速成長。

臨床測試將直接受益於生物技術（尤其是基因組學）的爆炸性發展。各種動態趨勢正在推動市場成長和公司估值。

本報告提供全球臨床檢驗服務市場相關調查，提供市場概要，以及各化驗類型，場所，各產品，各國趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場

第2章 簡介和市場定義

  • 臨床檢驗新的需求
  • 機會定義
  • 調查手法
  • 觀點:醫療保健和IVD產業

第3章 市場概要

  • 市場進入機關
    • 學術研究機關
    • 診斷測試開發商
    • 儀器供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 公共的國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關
  • 市場區隔- 各種方法
  • 臨床檢驗產業結構
  • 國家與地區的多樣性

第4章 推進不斷變化的市場的趨勢

  • 推動成長的多個方面
  • 市場縮小的要素
  • 自動化和研究室趨勢

第5章 臨床檢驗服務的最近的趨勢

第6章 主要企業的簡介

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Assurance Scientific Laboratories
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnosticos da America
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories
  • Mid America Clinical Laboratories
  • MNG Labs
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • OncoDNA
  • Pathology, Inc.
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Synlab
  • Sysmex Inostics
  • Unilabs
  • Werfen

第7章 全球臨床檢驗市場

  • 全球市場概要，各國
  • 全球市場概要，各化驗類型
  • 全球市場概要，各場所
  • 全球市場概要，各產品

第8章 全球臨床檢驗診斷市場- 各化驗類型

  • 化學
  • 微生物學
  • 血液學
  • 解剖病理學
  • 分子診斷
  • 難治性檢驗

第9章 全球臨床檢驗診斷市場- 場所

  • 住院病房
  • 門診病人醫院
  • 獨立研究所
  • 醫院檢驗室
  • 其他

第10章 全球臨床檢驗診斷市場- 各產品

  • 設備
  • 試劑
  • 人事費用
  • 間接費
  • 其他

第11章 臨床檢驗室的未來

第12章 附錄

Report Overview:

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. The New Demand for Clinical Testing
  • 2.2. Defining the Opportunity
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Segmentation - Different Approaches
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
  • 3.3. Structure of Clinical Testing Industry
    • 3.3.1. The Hospital Lab - Share of the Pie
    • 3.3.2. Key Role for Economies of Scale
    • 3.3.3. Physician Office Lab's are Still Here
    • 3.3.4. Physician's and POCT - Reviving Patient Service in China
  • 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

  • 4.1. Growth Is Pushed from Many Sides
    • 4.1.1. Demographic Impacts on Consumption
    • 4.1.2. COVID Related Impacts
    • 4.1.3. Point of Care Testing Makes a Difference
    • 4.1.4. Alternative Medicine Effect
    • 4.1.5. Esoterics
    • 4.1.6. A New Laboratory Discipline
  • 4.2. Factors at Work to Shrink the Market
    • 4.2.1. Where are Costs Going?
    • 4.2.2. Population Effects
    • 4.2.3. Management Practices
    • 4.2.4. Wellness
    • 4.2.5. Cannabilization
    • 4.2.6. Point of Care
  • 4.3. Automation and Laboratory Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Siemens Healthineers Reach New Level of Automation
  • 5.3. Clinical Laboratory Prostate Cancer Screening Concerns
  • 5.4. Clinical Labs Prepare for AI
  • 5.5. Self-Testing and AI to Change Clinical Labs
  • 5.6. Atalan Sees Potential in Hospital Outreach Business
  • 5.7. Challenge Bringing Routine Testing to Point of Care
  • 5.8. Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.9. Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.10. MedGenome Acquires Prognosis Laboratories
  • 5.11. Brooks Automation acquires Aim Lab
  • 5.12. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.13. Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.14. CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.15. Quest Diagnostics acquires Summa Health outreach lab
  • 5.16. Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.17. Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.18. Labcorp to Spin Off Clinical Development Business
  • 5.19. Value-Based Care Growing More Profitable for Labs
  • 5.20. Lucid Diagnostics Reports Revenue Growth
  • 5.21. NGS Cancer Testing Decision Appeases Industry
  • 5.22. Clinical Labs Make Strong Showing in 2021
  • 5.23. Seegene to Enter Syndromic MDx Space
  • 5.24. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.25. Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.26. ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.27. Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.28. EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.29. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.30. Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.31. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.32. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.33. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.34. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.35. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

  • 6.1. Acibadem Labmed Laboratory
  • 6.2. ACM Medical Laboratory
  • 6.3. Adicon Clinical Laboratories
  • 6.4. American Bio-Clinical Laboratories, Int'l
  • 6.5. ARUP Laboratories
  • 6.6. Ascend Clinical
  • 6.7. Assurance Scientific Laboratories
  • 6.8. Bio-Reference Laboratories
  • 6.9. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.10. BP Healthcare Group
  • 6.11. Clinical Reference Laboratory
  • 6.12. Clongen Laboratories
  • 6.13. CompuNet Clinical Laboratories
  • 6.14. Diagnosticos da America
  • 6.15. DIAN Diagnostics Co., Ltd.
  • 6.16. Enzo Biochem
  • 6.17. Eone Laboratories
  • 6.18. Eurofins Scientific
  • 6.19. Exagen Diagnostics
  • 6.20. Genzyme Corporation
  • 6.21. Gribbles Pathology
  • 6.22. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.23. Integrated Regional Laboratories
  • 6.24. KDL Group
  • 6.25. Laboratory Corporation of America
  • 6.26. Lifelabs
  • 6.27. Mayo Clinic Laboratories
  • 6.28. Mid America Clinical Laboratories
  • 6.29. MNG Labs
  • 6.30. Myriad Genetics/Myriad RBM
  • 6.31. NeoGenomics
  • 6.32. OncoDNA
  • 6.33. Pathology, Inc.
  • 6.34. ProPhase Labs
  • 6.35. Psychemedics Corporation
  • 6.36. Quest Diagnostics
  • 6.37. RDL Reference Laboratory
  • 6.38. Sonic Healthcare
  • 6.39. Sophia Genetics
  • 6.40. Spectra Laboratories
  • 6.41. Synlab
  • 6.42. Sysmex Inostics
  • 6.43. Unilabs
  • 6.44. Werfen

7. The Global Market for Clinical Laboratory Testing

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country
  • 7.2. Global Market by Assay Type - Overview
    • 7.2.1. Table - Global Market by Assay Type
    • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Assay Type - Base Year
    • 7.2.4. Chart - Global Market by Assay Type - End Year
    • 7.2.5. Chart - Global Market by Assay Type - Share by Year
    • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
  • 7.3. Global Market by Place - Overview
    • 7.3.1. Table - Global Market by Place
    • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Place - Base Year
    • 7.3.4. Chart - Global Market by Place - End Year
    • 7.3.5. Chart - Global Market by Place - Share by Year
    • 7.3.6. Chart - Global Market by Place - Segments Growth
  • 7.4. Global Market by Product - Overview
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3. Chart - Global Market by Product - Base Year
    • 7.4.4. Chart - Global Market by Product - End Year
    • 7.4.5. Chart - Global Market by Product - Share by Year
    • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1. Chemistry
    • 8.1.1. Table Chemistry - by Country
    • 8.1.2. Chart - Chemistry Growth
  • 8.2. Microbiology
    • 8.2.1. Table Microbiology - by Country
    • 8.2.2. Chart - Microbiology Growth
  • 8.3. Hematology
    • 8.3.1. Table Hematology - by Country
    • 8.3.2. Chart - Hematology Growth
  • 8.4. Anatomic Pathology
    • 8.4.1. Table Anatomic Pathology - by Country
    • 8.4.2. Chart - Anatomic Pathology Growth
  • 8.5. Molecular Diagnostics
    • 8.5.1. Table Molecular Diagnostics - by Country
    • 8.5.2. Chart - Molecular Diagnostics Growth
  • 8.6. Esoteric
    • 8.6.1. Table Esoteric - by Country
    • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1. In Patient Hospital
    • 9.1.1. Table In Patient Hospital - by Country
    • 9.1.2. Chart - In Patient Hospital Growth
  • 9.2. Out Patient Hospital
    • 9.2.1. Table Out Patient Hospital - by Country
    • 9.2.2. Chart - Out Patient Hospital Growth
  • 9.3. Independent Laboratory
    • 9.3.1. Table Independent Laboratory - by Country
    • 9.3.2. Chart - Independent Laboratory Growth
  • 9.4. Physicians Office Laboratory
    • 9.4.1. Table Physicians Office Laboratory - by Country
    • 9.4.2. Chart - Physicians Office Laboratory Growth
  • 9.5. Other Laboratory
    • 9.5.1. Table Other Laboratory - by Country
    • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1. Instruments
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instruments Growth
  • 10.2. Reagents
    • 10.2.1. Table Reagents - by Country
    • 10.2.2. Chart - Reagents Growth
  • 10.3. Labour
    • 10.3.1. Table Labour - by Country
    • 10.3.2. Chart - Labour Growth
  • 10.4. Overhead
    • 10.4.1. Table Overhead - by Country
    • 10.4.2. Chart - Overhead Growth
  • 10.5. Other Product
    • 10.5.1. Table Other Product - by Country
    • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus - Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: Factors Affecting Local Clinical Testing Demand
  • Table 6: Seven Factors Driving Growth
  • Table 7: Alternative Medicine Segments
  • Table 8: Six Factors Limiting Growth
  • Table 9: Seven Key Diagnostic Laboratory Technology Trends
  • Table 10 - Global Market by Region
  • Table 11: Global Market by Assay Type
  • Table 12: Global Market by Place
  • Table 13: Global Market by Product
  • Table 14: Chemistry by Country
  • Table 15: Microbiology by Country
  • Table 16: Hematology by Country
  • Table 17: Anatomic Pathology by Country
  • Table 18: Molecular Diagnostics by Country
  • Table 19: Esoteric by Country
  • Table 20: In Patient Hospital by Country
  • Table 21: Out Patient Hospital by Country
  • Table 22: Independent Laboratory by Country
  • Table 23: Physicians Office Laboratory by Country
  • Table 24: Other Laboratory by Country
  • Table 25: Instruments by Country
  • Table 26: Reagents by Country
  • Table 27: Labour by Country
  • Table 28: Overhead by Country
  • Table 29: Other Product by Country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Road to Diagnostics
  • Figure 3: The Changing Age of The World's Population
  • Figure 4: Health Care Consumption by Age
  • Figure 5: Cancer Incidence - Age at Diagnosis
  • Figure 6: Centralized vs. Decentralized Laboratory Service
  • Figure 7: A Highly Multiplexed Syndromic Testing Unit
  • Figure 8: The Real Cost to Sequence the Human Genome
  • Figure 9: The Codevelopment Process
  • Figure 10: Comparing MDx Diagnostic and Traditional Testing
  • Figure 11: Global Market Pareto Chart
  • Figure 12: Global Market by Assay Type - Base vs. Final
  • Figure 13: Global Market by Assay Type Base Year
  • Figure 14: Global Market by Assay Type End Year
  • Figure 15: Assay Type Share by Year
  • Figure 16: Assay Type Segments Growth
  • Figure 17: Global Market by Place - Base vs. Final
  • Figure 18: Global Market by Place Base Year
  • Figure 19: Global Market by Place End Year
  • Figure 20: Place Share by Year
  • Figure 21: Place Segments Growth
  • Figure 22: Global Market by Product - Base vs. Final
  • Figure 23: Global Market by Product Base Year
  • Figure 24: Global Market by Product End Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segments Growth
  • Figure 27: Chemistry Growth
  • Figure 28: Microbiology Growth
  • Figure 29: Hematology Growth
  • Figure 30: Anatomic Pathology Growth
  • Figure 31: Molecular Diagnostics Growth
  • Figure 32: Esoteric Growth
  • Figure 33: In Patient Hospital Growth
  • Figure 34: Out Patient Hospital Growth
  • Figure 35: Independent Laboratory Growth
  • Figure 36: Physicians Office Laboratory Growth
  • Figure 37: Other Laboratory Growth
  • Figure 38: Instruments Growth
  • Figure 39: Reagents Growth
  • Figure 40: Labour Growth
  • Figure 41: Overhead Growth
  • Figure 42: Other Product Growth